Want to create an interactive transcript for this episode?
Podcast: Keeping Current
Episode: Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic
Description: Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 6/20/2023 Earn Credit / Learning Objectives & Disclosures:Â https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726